Checkmate Pharmaceuticals, Inc. (CMPI) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 48 transactions totaling $29.3M, demonstrating a bearish sentiment with -$2.3M in net insider flow. The most recent transaction on May 16, 2022 involved a sale of 95,800 shares valued at $1.0M.
No significant insider buying has been recorded for CMPI in the recent period.
No significant insider selling has been recorded for CMPI in the recent period.
Based on recent SEC filings, insider sentiment for CMPI is bearish with an Insider Alignment Score of 46/100 and a net flow of -$2.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Checkmate Pharmaceuticals, Inc. (CMPI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading CMPI stock, having executed 48 transactions in the past 90 days. The most active insider is Global Strategic Gp Ii, Ltd. Venbio (Executive), who has made 8 transactions totaling $11.5M.
Get notified when executives and directors at CMPI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 16, 2022 | S. Goodman Corey | Executive | Sale | 95,800 | $10.45 | $1.0M | Large |
| May 13, 2022 | S. Goodman Corey | Executive | Sale | 35,850 | $10.45 | $374.6K | |
| May 12, 2022 | Strategic Fund II L.p. Venbio Global | Executive | Sale | 124,525 | $10.39 | $1.3M | Large |
| May 11, 2022 | Strategic Fund II L.p. Venbio Global | Executive | Sale | 17,700 | $10.38 | $183.7K | |
| May 10, 2022 | Strategic Fund II L.p. Venbio Global | Executive | Sale | 18,676 | $10.38 | $193.9K | |
| May 9, 2022 | Strategic Fund II L.p. Venbio Global | Executive | Sale | 17,600 | $10.37 | $182.5K | |
| May 6, 2022 | Strategic Fund II L.p. Venbio Global | Executive | Sale | 48,334 | $10.37 | $501.2K | Large |
| May 5, 2022 | Strategic Fund II L.p. Venbio Global | Executive | Sale | 20,743 | $10.37 | $215.1K | |
| May 4, 2022 | Strategic Gp Ii, Ltd. Venbio Global | Executive | Sale | 37,500 | $10.37 | $388.9K | |
| May 3, 2022 | Strategic Gp Ii, Ltd. Venbio Global | Executive | Sale | 79,475 | $10.37 | $824.2K | Large |
| May 2, 2022 | Strategic Gp Ii, Ltd. Venbio Global | Executive | Sale | 153,700 | $10.38 | $1.6M | Large |
| Apr 29, 2022 | Strategic Fund II L.p. Venbio Global | Executive | Sale | 69,230 | $10.38 | $718.6K | Large |
| Apr 28, 2022 | Strategic Fund II L.p. Venbio Global | Executive | Sale | 73,400 | $10.38 | $761.9K | Large |
| Apr 27, 2022 | Strategic Fund II L.p. Venbio Global | Executive | Sale | 47,396 | $10.38 | $492.0K | |
| Apr 26, 2022 | Strategic Gp Ii, L.p. Venbio Global | Executive | Sale | 64,683 | $10.38 | $671.4K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 23 | $15.8M | 54.0% |
Purchase(P) | 16 | $13.5M | 46.0% |
Exercise(M) | 3 | $21.0K | 0.1% |
Other(J) | 3 | $0 | 0.0% |
Conversion(C) | 3 | $0 | 0.0% |
Insider activity at Checkmate Pharmaceuticals, Inc. shows mixed signals across all time. While $13.5M in purchases indicates some executive confidence,$15.8M in sales balances the picture, resulting in a modest net flow of -$2.3M.8 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Global Strategic Gp Ii, Ltd. Venbio, has transacted $11.5M during this period.